Aditxt, Inc. revenue for the last year amounted to 999.00 k USD, the most of which — 645.18 k USD — came from its highest performing source at the moment, Immune Reprogramming Technologies, the year earlier bringing 933.72 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Aditxt, Inc. 645.18 k USD, and the year before that — 933.72 k USD.